azathioprine
azathioprine
1. The main selections of medicine were sulfasalazine (54.12%), mesalamine (18.82%) and metronidazole(21.18%) in 301 Hospital, while in CCF steroids (60.29%), azathioprine (33.82%) and infliximab (45.59%) were the main selections of medicine.
301医院药物治疗以柳氮磺吡啶(54·12%)、5-氨基水杨酸(18·82%)及甲硝唑(21·18%)为主,CCF以激素(60·29%)、硫唑嘌呤(33·82%)、infliximab(45·59%)为主。
2. The immunosuppression consisted of cyclosporine, azathioprine, and prednisolone.
免疫抑制剂包括环孢霉素、硫唑嘌呤和强的松龙。
3. Keywords azathioprine;liposome;entrapment ratio;quality evaluation;
关键词硫唑嘌呤;脂质体;包封率;质量评价;
4. Keywords Azathioprine tablets;adjuvant arthritis in mice;oxidation-resistant function;
关键词雷公藤多甙片;佐剂性关节炎;抗氧化作用;
5. Azathioprine has also been shown to have an anti-HCV effect in the replicon model [39].
同样，咪唑硫嘌呤也显示出抗病毒作用[39]。
6. If the use of western medicine, can be used immunosuppressive drugs such as azathioprine, not premature use of glucocorticoids.
如果使用西药，可用硫唑嘌呤等免疫抑制药，不要过早的使用皮质激素。
7. Keywords differential spectrophotometry;an automatic dissolution testing system;ofloxacin tablets;azathioprine tablets;
差示分光光度法;药物溶出与紫外联机系统;氧氟沙星片;硫唑嘌呤片;
8. Keywords Mercaptopurine （6-MP）;Azathioprine （BAN）;8-Azaguanine （8-Azan）;Cyclodextrin;Inclusion complexes;
巯嘌呤;硫唑嘌呤;8氮杂鸟嘌呤;环糊精;包合;
9. Keywords thiopurine methyltransferase（TPMT）;6-mercaptopurine;azathioprine;pharmacokinetics;
巯嘌呤甲基转移酶;6-巯基嘌呤;硫唑嘌呤;药动学;
10. Objective To assess the rate of side effects leading to discontinuation of azathioprine.
摘要目的评估炎性肠病患者使用硫唑嘌呤后因不良反应引起停药的比例及原因。
11. Treatment is with dietary modification and use of medications such as corticosteroids, metronidazole, sulfasalazine, and azathioprine.
治疗可以通过饮食调整和药物治疗，如皮质类固醇、甲硝唑、柳氮和硫唑嘌呤。
12. Keywords inflammatory bowel disease;azathioprine;6-mercaptopurine;thioprine methyltransferase;
炎性肠病;硫唑嘌呤;6-巯嘌呤;硫嘌呤甲基转移酶;
13. Keywords Inflammatory bowel disease;Side effects;Azathioprine;
炎性肠病;硫唑嘌呤;不良反应;
14. Side Effects of Azathioprine in Patients with Inflammatory Bowel Disease
炎性肠病患者服用硫唑嘌呤的不良反应及处理
15. It may be an effective substitute for azathioprine in treatment of leukocytopenia.
特别适用于术前白细胞总数较低的患者。
16. Azathioprine effective, if there spondylitis patients with psoriasis, it is better. 50-100 mg daily dosage.
用量每日50-100毫克。
17. Therapeutic Effects of High-dose Methylprednisolone Combined with Azathioprine on Immune Function in Patients with Myasthenia Gravis
甲基强的松龙与硫唑嘌呤联合治疗对重症肌无力临床和免疫功能的影响
18. To compare the effects of treatment methods between Mycophenolate mofetil(MMF)and azathioprine(AZT)combined with prednisone respectively in treating HBV_GN.
目的 :对比霉酚酸酯 (MMF)联合强的松与硫唑嘌呤联合强的松治疗乙肝病毒相关性肾炎 (HBV_GN)的疗效。
19. imoran azathioprine
硫唑嘌呤
20. Azathioprine ;Chromatin ;Mechanisms ;DNA ;exchange ;
硫唑嘌呤 ;
21. Spectrometric study on the interaction between Azathioprine and bovine serum albumin
硫唑嘌呤与牛血清白蛋白相互作用的热力学研究
22. Poisoning by azathioprine
硫唑嘌呤中毒
23. Study on the Preparation of Azathioprine Liposomes
硫唑嘌呤脂质体的研制
24. Clinical characteristics and enzymology basis of hematological crisis caused by azathioprine
硫唑嘌呤致血液系统危象的临床特征与酶学基础
25. azathioprine sodium
硫唑嘌呤钠盐
26. Results In 7 patients azathioprine was preliminary discontinued due to adverse events and in 6 of these patients(19.4%)adverse events occurred within 4 weeks after the onset of therapy.
结果7例患者因为出现不良反应而终止治疗,其中6例(19.4%)不良反应发生在用药4周内。
27. Results Cyclosporine A, azathioprine and methylprednisolone were the baseline immunosuppression management.
结果术后常规给予环孢素A、硫唑嘌呤和甲基强的松龙三联免疫抑制剂。
28. Conclusion Early adverse reaction is the main cause of azathioprine prema...
结论早期不良反应是引起炎性肠病患者停止硫唑嘌呤治疗的主要原因。
29. Keywords liver diseases;azathioprine;models;animal;transaminases;mice;
肝疾病;硫唑嘌呤;模型;动物;转氨酶类;小鼠;
30. These patients also were receiing drugs known as azathioprine or 6-mercaptopurine.
这些患者同时接受了硫唑嘌呤或巯基嘌呤治疗。
31. Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging
采用磁共振成像评估硫唑嘌呤治疗多发性硬化症患者脑部新损伤的疗效
32. Keywords mycophenolate mofetil;azathioprine;cyclosporin A;rejection;hepatic toxicity;
霉酚酸酯;硫唑嘌呤;环孢素A;排斥反应;肝毒性;
33. The profile and clinical significance of azathioprine metabolic enzymes activity in rheumatological patients
风湿病患者硫唑嘌呤代谢酶活性分布及其临床意义
